Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

SB investigates CCR3 receptor blockade as a novel approach to allergic, inflammatory disorders

Nov. 25, 1999

Advair approved in Canada, recommended for approval in U.S.

Nov. 25, 1999

Curosurf approved in U.S. for treatment of RDS in premature infants

Nov. 25, 1999

Sepracor and Abbott to copromote Xopenex in the U.S.

Nov. 22, 1999

Dual NK1/NK2 antagonist examined for disposition in rats

Nov. 22, 1999

RPR's new cell adhesion inhibitors especially useful for asthma, joint inflammation and IBD

Nov. 22, 1999

Potent, selective and stable tryptase inhibitors developed at Protherics

Nov. 22, 1999

Fournier's new bradykinin antagonists particularly useful for asthma, rhinitis

Nov. 16, 1999

Schering-Plough presents dual NK1/NK2 antagonists and their use in asthma, allergies, etc.

Nov. 16, 1999

Interferon gamma-1b offers possibilities as treatment for idiopathic pulmonary fibrosis

Nov. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
University of Western Australia patents 5-HT2A/B modulators
BioWorld Science
University of Western Australia has identified new lysergic acid diethylamide (LSD) analogues acting as 5-HT2A and 5-HT2B modulators reported to be useful for the...
Alceptor Therapeutics discovers new α2B-adrenoceptor agonists
BioWorld Science
Alceptor Therapeutics Inc. has patented new pyrazol-5-amine α2B-adrenoceptor agonists reported to be useful for the treatment of pain and hypertension.
EQ-504 is AhR agonist for ulcerative colitis, related disorders
BioWorld Science
Activating the aryl hydrocarbon receptor (AhR) in immune cells enhances anti-inflammatory pathways and limits pathogenic immune responses. Equillium Inc. has...
Quintuple GLP-1–GIP–PPAR agonist for obesity and diabetes control
BioWorld
A new molecule combines the action of two incretins, GLP-1 and GIP, hormones that regulate glucose and appetite, with lanifibranor, a triple agonist of peroxisome...